ORLANDO—A pilot program that instituted some small changes, including use of chlorhexadine scrubs the evening before surgery and then again 12 hours later on the morning of surgery, was able to reduce surgical site infections in one Ohio cancer center by almost 20% after 12 months.
ORLANDO—Patients often do not understand the terms clinicians use to describe their hematologic malignancies, such as myelodysplastic syndrome, which may lead to misunderstandings about their disease.
SAN DIEGO—Prostate cancer patients who are treated with a combination of androgen deprivation therapy (ADT) and radiotherapy may have a substantially improved chance of survival compared with patients who do not receive radiotherapy, according to British researchers. They reported at the 52nd annual meeting of the American Society for Radiation Oncology that combination therapy resulted in substantial benefits in overall survival and disease-specific survival in men with locally advanced prostate cancer.
I discovered my tumor by accident, shortly after taking custody of my two granddaughters. I was playing on the floor with them when one straddled my stomach and plopped down. The pain was unbelievable; I knew there was something very wrong. The many tests that followed were inconclusive, and my doctors thought it was a growth in my uterus so I was scheduled for a hysterectomy.
Cancer-related pain does not stop after the initial treatment period for almost 20% of survivors. In a first-of-its-kind study, researchers also found racial, in this study blacks, and sex, in this study women, disparities in cancer-related chronic pain.
Patient navigators facilitated almost 700 cancer screenings among Latino Medicare beneficiaries through a cancer prevention and treatment demonstration project for ethnic and racial minorities at the University of Medicine and Dentistry of New Jersey (UMDNJ). The project seeks to address disparities in cancer screening rates in the elderly Latino population in the Newark, New Jersey, area. The project also is evaluating the impact of navigators to facilitate that screening.
Multiple myeloma (MM) is a disease with variable presentation, disease trajectory, prognosis, and options for treatment. Integrating the plethora of scientific discovery relative to plasma cell disorders, molecular and cytogenetic attributes and their implications for prognosis and treatment, identification of key components of the bone marrow micro - environment, and the development of novel therapies targeting many of these attributes requires a thorough review of multiple sources of information. Multiple Myeloma: A Textbook for Nurses, edited by Joseph D. Read More ›
To sign up for our newsletter or print publications, please enter your contact information below.
